Investor Relations

Press Releases

 
Press Releases
Date Title and Summary View
Apr 27, 2017 PRINCETON, N.J., April 27, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (NASDAQ:AGRX), a women's healthcare company announced today that a presentation entitled "An Update on Hormonal Contraception and The Changing U.S. Population" will be presented by Co-Principal Investigator of the SECURE clinical trial, Anit...
Apr 11, 2017 PRINCETON, N.J., April 11, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's healthcare company, today announced it has received the final meeting minutes from its recent New Drug Application (NDA) pre-submission meeting with the U.S. Food and Drug Administration (FDA) for its lead product candidate, ...
Mar 16, 2017 PRINCETON, N.J., March 16, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's healthcare company, announced a poster presentation of data from the SECURE Phase 3 clinical trial for its lead product candidate, Twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known...
Mar 8, 2017 PRINCETON, N.J., March 08, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company today reported financial results for the three months and year ended December 31, 2016 and provided a corporate update for the fourth quarter 2016. ...
Mar 1, 2017 PRINCETON, N.J., March 01, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women's health specialty pharmaceutical company announced today that its Chief Executive Officer, Al Altomari will present at 29th Annual ROTH Conference on Monday, March 13, 2017 at 4:30 PM Pacific Time. The conference is being held ...
Feb 14, 2017 PRINCETON, N.J., Feb. 14, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women's health specialty pharmaceutical company, announced today that its Chief Executive Officer, Al Altomari will present at the RBC Capital Markets 2017 Global Healthcare Conference on February 23, 2017 at 10:00 AM ET at the New York Palace in New ...
Feb 2, 2017 PRINCETON, N.J., Feb. 02, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women's health specialty pharmaceutical company, announced today that its Chief Executive Officer, Al Altomari will present at the 2017 BIO CEO & Investor Conference on Monday, February 13, 2017 at 11:00 am ET at the Waldorf Astoria in...
Jan 19, 2017 PRINCETON, N.J., Jan. 19, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women's health specialty pharmaceutical company, announced today that its Chief Executive Officer, Al Altomari will present at Noble Capital Markets' Thirteenth Annual Investor/ Equity Conference on Tuesday, January 31, 2017 at 11:00 am E...
Jan 3, 2017 Resubmission of Twirla® New Drug Application Expected to Address FDA's Complete Response LetterCompany Plans to Resubmit NDA in First Half of 2017            Company to Host Conference Call on January 3, 2017 at 5:00 p.m...
Dec 22, 2016 PRINCETON, N.J., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) announced today that its Chief Executive Officer, Al Altomari will present at the Biotech Showcase 2017 on Monday, January 9, 2017 at 9:00 AM Pacific Time.   The conference will be held at the Hilton San Francisco Union Square....
Page:
1
... NextLast
= add release to Briefcase